CASTRATION-RESISTANT PROSTATE CARCINOMA
Clinical trials for CASTRATION-RESISTANT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted drug trial aims to starve advanced cancers by blocking their DNA repair
Disease control Recruiting nowThis study is testing whether the drug talazoparib can help control advanced cancers in patients whose tumors have specific genetic mutations that affect how cells repair damaged DNA. The trial will enroll about 36 adults with various advanced solid tumors (like breast, ovarian, …
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 22:41 UTC
-
DNA-Guided trial aims to outsmart advanced prostate cancer
Disease control Recruiting nowThis study is testing whether using genetic information from a patient's tumor can help doctors choose a more effective treatment for advanced prostate cancer that has stopped responding to standard hormone therapy. About 474 men will have their tumor's DNA and RNA analyzed, and …
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New 'Living Drug' trial targets incurable prostate cancer
Disease control Recruiting nowThis study is testing a new cell therapy called STEAP1 CART, given with the hormone drug enzalutamide, for men with advanced prostate cancer that has spread and no longer responds to standard treatments. The trial aims to find a safe dose and see if this combination can shrink tu…
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug combo trial offers hope for Tough-to-Treat prostate cancer
Disease control Recruiting nowThis study is testing if adding the drug carboplatin to the standard chemotherapy cabazitaxel works better than cabazitaxel alone for men with advanced prostate cancer that has spread and no longer responds to hormone therapy. Researchers will enroll about 528 participants and gr…
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Fighting fire with fire: High-Testosterone therapy aims to shock resistant prostate cancer
Disease control Recruiting nowThis study is testing if giving very high doses of testosterone, along with chemotherapy or a targeted radiation drug, can help control advanced prostate cancer that has spread and stopped responding to standard hormone-blocking treatments. The idea is to shock cancer cells that …
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Study asks: can a break from prostate cancer treatment be just as effective?
Disease control Recruiting nowThis study is testing whether patients with advanced prostate cancer that has spread can safely take a break from their targeted radiation treatment. Researchers want to see if stopping treatment after 5 cycles and only resuming if the cancer worsens works as well as getting the …
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Scientists test re-engineered immune cells to fight spreading prostate cancer
Disease control Recruiting nowThis early-stage study is testing the safety and best dose of a personalized immune therapy for men with advanced prostate cancer that has spread and stopped responding to standard hormone treatments. Doctors take a patient's own immune cells, modify them in a lab to better targe…
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for Tough-to-Treat prostate cancer
Disease control Recruiting nowThis study is testing if adding a drug called vorinostat makes a newer radioactive cancer treatment work better for men with advanced prostate cancer. The cancer has spread and stopped responding to standard hormone treatments. Researchers want to see if vorinostat can 'turn on' …
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Second shot at life: repeating a Cancer-Killing radiation treatment
Disease control Recruiting nowThis study is testing whether giving a second course of a targeted radiation drug can help men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. The treatment, called 177Lu-PSMA-617, is given by IV and seeks out and delivers radiati…
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for tough prostate cancer: Two-Drug attack begins human testing
Disease control Recruiting nowThis early-stage study is testing whether adding the drug ruxolitinib to the standard treatment enzalutamide is safe and effective for men with advanced prostate cancer that has stopped responding to hormone-blocking therapy. The goal is to find the best dose and see if this comb…
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
DNA clues could predict which prostate cancer patients benefit from Bone-Targeting drug
Disease control Recruiting nowThis study aims to understand why some men with advanced prostate cancer that has spread to bones respond better to the drug radium-223 than others. Researchers will test blood samples from 48 patients to look for specific DNA repair defects that might make the cancer more sensit…
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Sponsor: University of Washington • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Paradoxical approach: giving testosterone to fight prostate cancer
Disease control Recruiting nowThis early-stage study is testing a counterintuitive approach for men with advanced prostate cancer that has stopped responding to standard hormone-blocking treatments. Researchers are giving patients cycles of testosterone injections to see if rapidly switching between very low …
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
Scientists test Two-Drug punch for tough prostate cancer
Disease control Recruiting nowThis study is testing a two-step treatment for advanced prostate cancer that has spread and stopped responding to standard hormone therapies and chemotherapy. First, patients take a pill (abemaciclib) for two weeks, aiming to make cancer cells more visible. Then, they receive a t…
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Vadim S Koshkin • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Freezing cancer to stop the pain: new combo therapy trial
Symptom relief Recruiting nowThis study is testing if adding a freezing procedure (cryoablation) to standard radiation therapy works better to relieve pain from cancer that has spread to the bones. Researchers will compare the combination treatment to radiation alone in 40 patients with advanced cancers. The…
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
Scientists probe prostate Cancer's defenses against radiation
Knowledge-focused Recruiting nowThis study aims to learn why some advanced prostate cancers become resistant to a targeted radiation treatment called 177Lu-PSMA therapy. Researchers will take small tissue samples (biopsies) from 30 patients before and during their treatment to analyze the cancer cells. The goal…
Matched conditions: CASTRATION-RESISTANT PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC